---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-010520"
form_type: "8-K"
ticker: "HROW"
cik: "0001360214"
company_name: "HARROW, INC."
filed_at: "2024-03-19T23:59:59+00:00"
generated_at: "2026-06-04T13:07:53.320515+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Harrow full-year 2023 revenue $130.2M (+47% YoY), GAAP net loss widens to $24.4M; adj EBITDA $28.1M

## Summary
- FY2023 revenue $130.2M, up 47% YoY; GAAP net loss $24.4M (vs $14.1M loss in 2022).
- Adjusted EBITDA $28.1M, +116% YoY; cash from ops $3.8M full-year, $8.7M in Q4.
- IHEEZO Q4 reorder rate 83%; Q1 2024 sales impacted by Change Healthcare cyberattack; CMS added J-code to ASP file.
- VEVYE launch exceeding expectations; 70% refill rate; over 40M covered lives including TriCare and Aetna.
- TRIESENCE first PPQ batch scheduled for April 15; NDA transferred; price set at $944/unit; targeting 90K units inventory.

## SEC filing metadata
- accession: 0001493152-24-010520
- form_type: 8-K
- ticker: HROW
- cik: 0001360214
- company_name: HARROW, INC.
- filed_at: 2024-03-19T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1360214/000149315224010520/0001493152-24-010520-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1360214/000149315224010520/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-010520
- JSON: https://secwatch.observer/filing/0001493152-24-010520.json
- Plain text: https://secwatch.observer/filing/0001493152-24-010520.txt

## Key facts
- Earnings Releases
  HARROW, INC. reported the year and quarter ended December 31, 2023 results: revenue $130,193,000, net income $(24,411,000), EPS $(0.75).
  - Period: the year and quarter ended December 31, 2023
  - Revenue: $130,193,000
  - Net income: $(24,411,000)
  - EPS: $(0.75)
  - Result: reported results
  source text: Form 8-K. --- EX-99.1 () --- EX-99.1 2 ex99-1.htm Exhibit 99.1 Harrow Announces Fourth Quarter and Year-End 2023 Financial Results Full-Year 2023 Highlights: ● Revenues of $130.2 million, an increase of 47% over 2022 revenues of $88.6 million. ● GAAP net loss of $(24.4 million) compared with $(14.1 million) for the prior-year period. ● Adjusted EBITDA of $28.1
  evidence_url: https://www.sec.gov/Archives/edgar/data/1360214/000149315224010520/0001493152-24-010520-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.